Document is current
Any future updates will be listed below
-
Authors
Jakobsen, Johannes
Karam, Chafic
Kuitwaard, Krista
Levine, Todd
- License Information
-
More Information
Article History
Received: 12 March 2026
Accepted: 5 June 2026
First Online: 11 July 2026
Declarations
:
: Johannes Jakobsen has received payment or honoraria for lectures, presentations, or educational events from Takeda. Chafic Karam has received grants or contracts from Ionis and Argenx in the past 36 months and consultancy fees from Alexion, Alnylam, Alpine, Amgen, Amicus, Annexon, Argenx, AstraZeneca, Biogen, Corino, CSL Behring, Genentech, Ionis, J&J, Neuroderm, Novo Nordisk, Octapharma, Pfizer, Sanofi, Takeda, UCB, Vertex, and Zai Lab. Krista Kuitwaard has received research grants from Albert Schweitzer Hospital, Takeda, and the For Wis(h)dom Foundation in the past 36 months, consultancy fees from Takeda, speakers fees from Grifols and Octapharma, and support for attending meetings and travel from GBS-CIDP Foundation International and Octapharma. Todd Levine is a consultant for FFF Enterprises and is on the speakers bureau for Grifols.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
